Elevation Pharmaceuticals

Elevation Pharmaceuticals, founded in 2008, is developing an improved series of aerosol drug products for COPD patients. The founding team has a successful track record in establishing companies and has built a dedicated team to develop new drug products that enhance patients' lives. At Elevation, they employ a rigorous approach to strategic decision-making, focusing on the path with the highest probability of success. They execute their drug development programs with passion, integrity, and a strong sense of urgency to meet the needs and expectations of stakeholders – employees, investors, partners, and patients.